Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial

Summary Background Probiotic bacteria may be effective in the treatment of allergic inflammation and food allergy, but efficacy and underlying mechanisms remain unclear. Objective The present study investigated the effects of probiotic strain Bifidobacterium longum BB536 in the treatment of Japanese...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental allergy 2006-11, Vol.36 (11), p.1425-1435
Main Authors: Xiao, J.-Z., Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, K., Enomoto, T.
Format: Article
Language:English
Subjects:
Adult
Allergic diseases
allergy
Antibodies - blood
Bifidobacterium
Bifidobacterium longum
Biological and medical sciences
Biomarkers - blood
Chemokine CCL17
Chemokines, CC - blood
Cryptomeria - immunology
Cryptomeria japonica
cytokine
Cytokines - blood
Double-Blind Method
eosinophil
Eosinophilia - immunology
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Immunoglobulin E - blood
Immunopathology
Interferon-gamma - blood
Interleukin-10 - blood
Japanese cedar pollinosis
Male
Medical sciences
probiotic
Probiotics - administration & dosage
Rhinitis, Allergic, Seasonal - therapy
Statistics, Nonparametric
Surveys and Questionnaires
Th1 Cells - immunology
Th2 Cells - immunology
thymus and activation-regulated chemokine (TARC)
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background Probiotic bacteria may be effective in the treatment of allergic inflammation and food allergy, but efficacy and underlying mechanisms remain unclear. Objective The present study investigated the effects of probiotic strain Bifidobacterium longum BB536 in the treatment of Japanese cedar pollinosis (JCPsis). Methods In a randomized, double‐blind, placebo‐controlled trial, 44 JCPsis subjects received BB536 or placebo for 13 weeks during the pollen season. Subjective symptoms and self‐care measures were recorded daily and blood samples were taken before and during intervention to measure blood levels of parameters related to JCPsis. Results BB536 intake was associated with a significant reduction in number of subjects prematurely terminated due to severe symptoms and pollinosis medication (P=0.0057 vs. placebo group). Comparison of subjective symptom scores indicated significant decreases in rhinorrhea, nasal blockage and composite scores in the BB536 group compared with the placebo group. Comparison of medical scores showed marked improvements in all symptoms on BB536 intake. A T‐helper type 2 (Th2)‐skewed immune response occurring along with pollen dispersion was observed. BB536 significantly suppressed increases in plasma thymus‐ and activation‐regulated chemokine and tended to suppress elevations of Japanese cedar pollen (JCP)‐specific IgE. Conclusion These results suggest the efficacy of BB536 in relieving JCPsis symptoms, probably through the modulation of Th2‐skewed immune response.
ISSN:0954-7894
1365-2222
DOI:10.1111/j.1365-2222.2006.02575.x